C2i Genomics introduces minimal residual disease test for cancer in Europe
C2inform eliminates the need for patient-specific assay development and offers a rapid solution for cancer patients.
Diagnostic Imaging
Latest in
Diagnostic Imaging
KSL Diagnostics introduces new antibody test for Covid-19
The blood test measures antibodies that are specific to Covid-19, which develop in response to vaccination or infection.
US FDA grants EUA for Helix COVID-19 self-collection kit
The Helix COVID-19 Self-Collection Kit will be available to consumers from participating pharmacies and urgent care centres.
Covid-19 spurred on the self-testing revolution
Thanks to Covid-19, self-testing has become a common practice. Throughout the next few years, experts believe that this will continue…
By
Cancer Research UK-funded study finds new test for persistent lung cancer
The LUCID-DNA study showed that circulating tumour DNA can reveal the state, location and weaknesses of a tumour.
Health Canada authorises bioLytical’s Covid-19 antigen test
The new test is portable and can be performed at home with easy-to-understand results.
ReaGene Innovations licenses Covid-19 tests to Lay Science
The patent-pending ELISA and FAST FLOW SPOT tests both require an individual's saliva sample.
BillionToOne raises $125m through Series C round
The company will use the funding to conduct clinical trials of its Unity Screen prenatal liquid biopsy test.